Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Counci
about
Effect of emollients containing vegetable-derived lactobacillus in the treatment of atopic dermatitis symptoms: split-body clinical trial.Atopic dermatitis. Perspectives on a manageable disease.Managing pediatric atopic dermatitis.What's new in atopic dermatitis?Down-regulation of 11β-hydroxysteroid dehydrogenase type 2 by bortezomib sensitizes Jurkat leukemia T cells against glucocorticoid-induced apoptosis.Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema.Bee venom ameliorates compound 48/80-induced atopic dermatitis-related symptoms.Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema.Skin prick test in patients with chronic allergic skin disorders.A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea.Treatment of Atopic Dermatitis From the Perspective of Traditional Persian Medicine: Presentation of a Novel Therapeutic Approach.A major susceptibility locus for atopic dermatitis maps to chromosome 3q21.Dexamethasone as endocrine disruptor; type I and type II (anti) oestrogenic actions on the ovary and uterus of adult Wistar rats ()
P2860
Q33682076-1766E15E-77F9-4542-B2AB-1987A3AAA327Q33758839-4DCF6D68-3B4F-48D7-9A68-F23BAD90327BQ33830439-D4C22FF3-8A5B-4085-920A-4F3DCFF85105Q34352747-D6819E52-39B5-471F-858A-FB5AD0A54626Q34796376-772990B9-00BC-4FD8-A39D-D626493DB5B9Q35809490-4626C6FA-9A8E-4638-BAA6-D26820E79E89Q37049986-F1997FD0-EDE6-4DDF-ACEB-F21B52D10DAEQ37349502-D964FB49-F285-49AE-A28C-9BAF318E38A7Q37977478-C5B2C937-8D5A-4847-9F95-6139E386BBA3Q38123240-03D78B92-71FD-4947-88A0-037548DCF6CAQ41911070-3305FCAC-D64A-4A42-BAD9-215F6289807DQ44750207-B6C7193E-033F-4872-AD6C-37ABE62B6F12Q47388285-C1EA4F73-9F40-4783-9967-0DD716613356Q52967895-B4CFC94B-4A96-4CB6-A963-AF1CCBC2FD16Q58790395-D1781819-A590-4A9A-8A3E-AB31C3D22EF7
P2860
Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Counci
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Disease management of atopic d ...... munology, and the Joint Counci
@ast
Disease management of atopic d ...... munology, and the Joint Counci
@en
Disease management of atopic d ...... munology, and the Joint Counci
@nl
type
label
Disease management of atopic d ...... munology, and the Joint Counci
@ast
Disease management of atopic d ...... munology, and the Joint Counci
@en
Disease management of atopic d ...... munology, and the Joint Counci
@nl
prefLabel
Disease management of atopic d ...... munology, and the Joint Counci
@ast
Disease management of atopic d ...... munology, and the Joint Counci
@en
Disease management of atopic d ...... munology, and the Joint Counci
@nl
P2093
P1476
Disease management of atopic d ...... munology, and the Joint Counci
@en
P2093
Bernstein IL
Blessing-Moore J
Charlesworth EN
Hanifin JM
Nicklas RA
P304
P356
10.1016/S1081-1206(10)63003-7
P577
1997-09-01T00:00:00Z